Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) Price Target at $16.75
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year […]
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 year […]
